LONDON'S GLOBAL UNIVERSITY
Prostate Cancer Sleep Project
Sleep and prostate cancer: what is the link and the effect of treatment?
Prostate cancer is one of the most common cancers among men. About 1 in 8 men will get prostate cancer in their lifetime. Prostate cancer mainly affects men over 50, and your risk increases with age.
A limited body of evidence suggests that sleep problems are common in prostate cancer patients undergoing androgen deprivation therapy. It is well established that chronic sleep problems lead to reduced cognitive functioning and an increased risk of several major causes of shorter life expectancy. However, research into sleep problems and daily functioning in prostate cancer patients is limited.
As a result, our multidisciplinary team are working towards providing an objective assessment of sleep quality and quantity to establish the impact of hormonal treatment on sleep patterns in prostate cancer patients.
If you have any questions about the project please feel free to contact us using the contact details below or through our Facebook or Twitter pages.
The principal investigator on the project is Dr Dagmara Dimitriou (UCL) Director of the SERL
who is working with Dr Stephen Mangar MB ChB MRCP FRCR MSc MD. (Imperial College London) Consultant Clinical Oncologist.
Contact details of the research team:
Dr Dagmara Dimitriou email@example.com.
If you wish to provide a donation to the SERL to help with this research please click on the link below.
How do sleep and prostate cancer influence each other, and what is the impact of hormonal treatment on sleep patterns?